Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Other Working Capital Changes of -$1.4 million for Q1 2026, up 8.56% year-over-year from -$1.3 million in Q1 2025, and down 14.61% quarter-over-quarter from -$1.3 million in Q4 2025.
Analysis
Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 8.56% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$5.6 million (up 7.25% YoY), while the FY2025 annual figure was -$5.8 million, up 7.93% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.4 million, down from -$1.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $7.0 million in Q1 2025, with the low at -$4.5 million in Q3 2022.
- The 5-year median for Other Working Capital Changes is $36000.0 (2024), against an average of $429058.8.
- Peak annual rise in Other Working Capital Changes reached 1626.02% in 2022, while the deepest fall reached 14984.75% in 2022.
- Scholar Rock Holding's Other Working Capital Changes stood at $219000.0 in 2022, then plunged by 136.53% to -$80000.0 in 2023, then plunged by 1808.75% to -$1.5 million in 2024, then gained by 17.55% to -$1.3 million in 2025, then slipped by 14.61% to -$1.4 million in 2026.
- Business Quant data shows SRRK's Other Working Capital Changes at -$1.4 million in Q1 2026, -$1.3 million in Q4 2025, and -$1.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 7.25 Bn | 7.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.91 Mn |
| Jun 30, 2026 | -4.91 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -11.74 Mn |
| Dec 31, 2025 | -11.74 Mn |
| Sep 30, 2025 | -4.09 Mn |
| Sep 30, 2025 | -4.09 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | -12.01 Mn |
| Dec 31, 2024 | -12.01 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | -1.51 Mn |
| Mar 31, 2024 | -1.77 Mn |
| Mar 31, 2024 | -1.77 Mn |